The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors
Alex Berndt(Max Planck Institute of Molecular Physiology), Roger Williams(MRC Laboratory of Molecular Biology), Joseph I. Pacold(MRC Laboratory of Molecular Biology), Matthias Schwarz(Merck Serono S.A. (Switzerland)), Simon Miller(High Energy Accelerator Research Organization), Christian Rommel(Intel (United States)), Benjamin T. Houseman(Howard Hughes Medical Institute), Kevan M. Shokat(Howard Hughes Medical Institute), Yi Liu(Zhejiang University of Technology), Daniel D. Le(Howard Hughes Medical Institute), Olusegun Williams(Howard Hughes Medical Institute), Pingda Ren(Intel (United States)), Wai‐Ching Hon(MRC Laboratory of Molecular Biology), P. Gaillard(Merck Serono S.A. (Switzerland)), Thomas Rückle(Merck Serono S.A. (Switzerland)), Jeffrey P. Shaw(Brandeis University), F. Gorrec(MRC Laboratory of Molecular Biology)
Cited by 292
Related Papers
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k